Patents by Inventor Kyle BATTISTON

Kyle BATTISTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20250049719
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: June 10, 2024
    Publication date: February 13, 2025
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20230225975
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: February 16, 2023
    Publication date: July 20, 2023
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • Ocular inserts comprising a covalently linked steroid dimer
    Patent number: 11612567
    Abstract: The disclosure relates to compounds and compositions for sustained release of ocular therapeutics.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: March 28, 2023
    Assignee: RIPPLE THERAPEUTICS CORPORATION
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Wendy Alison Naimark, Hans Christian Fischer, Leonard Pinchuk
  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20210205222
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: January 8, 2021
    Publication date: July 8, 2021
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK, Roseita Esfand
  • GLASS FORMULATIONS AND USES THEREOF
    Publication number: 20210113457
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: February 1, 2019
    Publication date: April 22, 2021
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • Biomaterial with reduced inflammatory response
    Patent number: 10973950
    Abstract: Polar hydrophobic ionic materials and, in particular, polar hydrophobic ionic polyurethanes having a minimum ratio of hydrophobic and anionic components to the remainder of the polymer components are provided that exhibit reduced IgG Fab exposure.
    Type: Grant
    Filed: August 14, 2015
    Date of Patent: April 13, 2021
    Assignee: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
    Inventors: Paul Santerre, Kyle Battiston
  • Dexamethasone prodrug compositions and uses thereof
    Patent number: 10959954
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Grant
    Filed: November 27, 2019
    Date of Patent: March 30, 2021
    Assignee: RIPPLE THERAPEUTICS CORPORATION
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Hans Christian Fischer, J. Paul Santerre, Wendy Alison Naimark, Roseita Esfand
  • Dexamethasone prodrug compositions and uses thereof
    Patent number: 10945958
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: March 16, 2021
    Assignee: RIPPLE THERAPEUTICS CORPORATION
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Hans Christian Fischer, J. Paul Santerre, Wendy Alison Naimark
  • OCULAR INSERTS COMPRISING A COVALENTLY LINKED STEROID DIMER
    Publication number: 20210030667
    Abstract: The disclosure relates to compounds and compositions for sustained release of ocular therapeutics.
    Type: Application
    Filed: February 1, 2019
    Publication date: February 4, 2021
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Wendy Alison NAIMARK, Hans Christian FISCHER, Leonard PINCHUK
  • Glass formulations and uses thereof
    Patent number: 10632075
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: April 28, 2020
    Assignee: Ripple Therapeutics Corporation
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Hans Christian Fischer, J. Paul Santerre, Wendy Alison Naimark
  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20200113834
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: November 29, 2019
    Publication date: April 16, 2020
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20200113833
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: November 27, 2019
    Publication date: April 16, 2020
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • Dexamethasone prodrug compositions and uses thereof
    Patent number: 10588862
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: March 17, 2020
    Assignee: Ripple Therapeutics Corporation
    Inventors: Ian Charles Parrag, Matthew Alexander John Statham, Kyle Battiston, Dimitra Louka, Hans Christian Fischer, J. Paul Santerre, Wendy Alison Naimark
  • GLASS FORMULATIONS AND USES THEREOF
    Publication number: 20190275167
    Abstract: The disclosure features pharmaceutical compositions formed from prodrug dimers for the extended delivery of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: April 26, 2019
    Publication date: September 12, 2019
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK
  • DEXAMETHSONE PRODRUG COMPOSITIONS AND USES THEREOF
    Publication number: 20190247311
    Abstract: The disclosure features dexamethasone prodrug dimers of dexamethasone and pharmaceutical compositions thereof useful for, e.g., the extended release of a drug and for the treatment of a disease or condition.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 15, 2019
    Inventors: Ian Charles PARRAG, Matthew Alexander John STATHAM, Kyle BATTISTON, Dimitra LOUKA, Hans Christian FISCHER, J. Paul SANTERRE, Wendy Alison NAIMARK